Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04020185 |
Title | Safety and Efficacy Study of IMSA101 in Refractory Malignancies |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | ImmuneSensor Therapeutics Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Honor Health | Scottsdale | Arizona | 85260 | United States | Details | |
UC San Diego Moores Cancer Center | La Jolla | California | 92093 | United States | Details | |
Northwestern University | Chicago | Illinois | 60611 | United States | Details | |
Atlantic Health System/Morristown Medical Center | Morristown | New Jersey | 07962 | United States | Details | |
UT Southwestern | Dallas | Texas | 75390 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |